Skip to main content
Fig. 3 | Journal of Hematology & Oncology

Fig. 3

From: Immune phenotypes predict survival in patients with glioblastoma multiforme

Fig. 3

Differences in CD56 and CD16/56 NK cells and CD3/56 cytokine-activated NK (CIK) cells in GBM patients and controls. Percent CD cluster-positive lymphocytes are shown for patients (P) and healthy donors (H) on the left; relative expression densities, given as MFI are shown in the middle column, and absolute numbers of CD cluster-positive lymphocytes for the patients are shown on the right half of the figure. CD56 NK cells (a). CD56/16 co-expressing, activated NK cells (b). CD3/56 co-expressing, cytokine-induced killer (CIK) cells (c). IDH-1mutated patients outside of the 25-75 boxed percentile are shown as red-filled circles

Back to article page